Caldera Therapeutics
PrivateLast Round
Series A
Extension
Jan 14, 2026
Total Funding Raised
$112.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Caldera Therapeutics is a clinical stage biotechnology company developing CLD-423, a first-in-class bispecific antibody for the treatment of inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Caldera Therapeutics Comparables
Compare Caldera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bionyra Pharma | 94% | |
| TrueLab Biopharmaceutical | 88% | |
| Spyre Therapeutics Inc. | 84% | |
Caldera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 14, 2026 | ||||
| Series A | Apr 23, 2025 |
Caldera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series A Extension |
| Omega Funds | Series A Extension |
| Accomplice | Series A Extension, Series A |
| venBio | Series A Extension, Series A |
| Wellington Management | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 97% MoM, reaching 2K.
- Jul 25, 2026
Grew 63% QoQ, from 8 to 13 employees.
Caldera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Caldera Therapeutics's valuation, stock price, and market status.